White label – Pompe disease - ClinicalTrials.eu

Study on the Long-Term Safety of Isatuximab for Adults with Multiple Myeloma Benefiting from Isatuximab Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+1
Study on Cefepime for Patients with Chronic Kidney Disease on Peritoneal Dialysis Without Peritonitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Peritoneal dialysis
Investigated Drugs:
- Cefepime
Study on the Safety and Tolerability of BMS-986435 in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)

Not recruiting

2 1 1
Investigated Diseases:
- Heart failure with preserved ejection fraction
Investigated Drugs:
- Bms-986435
Study on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Povetacicept
Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+8
Study on Zanubrutinib for Patients with Primary Cold Agglutinin Disease

Not recruiting

2 1 1
Investigated Drugs:
- Zanubrutinib
Study on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis

Not recruiting

2 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Burfiralimab
Study of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Not recruiting

2 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Rezpegaldesleukin
+1
Study of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers

Not recruiting

1 1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies